BioSpace News Archive

Drug Development

Only Days After Hinting at an IPO, PureTech Acquires Lymphedema Asset

The asset, LYT-100, is an oral compound that has shown anti-fibrotic and anti-inflammatory properties.

July 17, 2019
·
3 min read
·
Mark Terry
Drug Development

Mallinckrodt Halts Midstage ALS Trial Over Safety Concerns

A disproportionate number of ALS patients on the investigational drug developed pneumonia.

July 17, 2019
·
2 min read
·
Alex Keown
Business

Kite’s Belldegrun Launches Biotech-Focused Real Estate Company, Breakthrough Properties

Arie Belldegrun, founder and former chair, president and chief executive officer of Kite Pharma, has teamed up with real estate developer Tishman Speyer to launch a biotech-focused real estate company, Breakthrough Properties.

July 17, 2019
·
3 min read
·
Mark Terry
Business

Gilead CSO, Other Executives, Departing Company as CEO Continues to Reshape C-Suite

Daniel O’Day took over the reins of Gilead Sciences in March and has been building his team of lieutenants.

July 17, 2019
·
2 min read
·
Alex Keown
Business

Deals, Deals, Deals: Astellas and Frequency, Orum, ImmunoCellular and Pyxis Oncology

There’s been quite a few small and mid-sized deals announced today. Let’s take a look at four of them.

July 17, 2019
·
3 min read
·
Mark Terry
Business

Adocia Presents First Half 2019 Financial Results

Adocia, the clinical-stage biopharmaceutical company focused on the treatment of diabetes and other metabolic diseases with innovative formulations of proteins and peptides, announces its financial results for the first six months ended June 30, 2019.

July 17, 2019
·
10 min read
Drug Development

Inovio, Amneal Slash Workforces as Both Companies Undergo Realignments

More than 600 employees will lose their jobs as the companies reshape their corporate strategies.

July 17, 2019
·
2 min read
·
Alex Keown
Business

BioSpace Global Roundup, July 18

Pharma and biotech companies from across the globe provide updates on their pipelines and corporate strategy.

July 17, 2019
·
6 min read
·
Alex Keown
Business

New insight into microRNA function can give gene therapy a boost

Scientists at the University of Eastern Finland and the University of Oxford have shown that small RNA molecules occurring naturally in cells, i.e. microRNAs, are also abundant in cell nuclei.

July 17, 2019
·
2 min read
Drug Development

Summit Highlighted Potential of SMT-571 to Combat the Rising Global Health Threat of Gonorrhoea at STI & HIV World Congress

Summit Therapeutics plc announced that it highlighted the potential of its preclinical new class antibiotic, SMT-571, to treat all gonorrhoea, including multi-drug and extensively-drug resistant strains, in a poster presentation at the STI & HIV World Congress in Vancouver, Canada.

July 17, 2019
·
6 min read